Pathology has struggled to de ne and implement changes to improve requesting practices, yet, with the increasing transfer of care from secondary to primary care, our workloads are increasing out of proportion to health care activity. Conversely, some tests appear to be considerably under-used by some general practitioners. Aspects of service recon guration such as rationalization of low-volume testing and joint equipment and reagent procurement may release some savings, although any such nancial bene ts are likely to be quickly nulli ed by the continued rise in activity and do not contribute to quality of test use. With very large differences between general practices in their use of pathology tests, this review looks at methods for changing pathology requesting activity and calls for involvement from professional organizations to support such initiatives.
Introduction
Advising on the optimal use of laboratory tests is, and has always been, a fundamental part of the clinical biochemist's remit, so there is nothing new in the concept of appropriateness of test use. However, the last 10 years have seen major changes in the manner in which the National Health Service (NHS) is organized and how budgets are funded, in particular with a shift in emphasis from secondary to primary care and transfer of an increasing proportion of contracting and budgeting decisions into primary care. The present government's promise of signi¢cant further funds to the NHS, tied to demonstrable improvements in quality, adds further emphasis to the subject of best use of tests in laboratory medicine, alongside the issues of restructuring service provision that formed the main thrust of the pathology modernization draft document. 1 Many di¤culties faced by pathology have their origin in a relentless increase in activity in the face of diminishing budgets rather than in the e¤ciency or ine¤ciency of service delivery. The need to examine use of pathology tests in view of the increasing primary care management of diabetes and other chronic diseases and coronary prevention was well illustrated in a recent presentation 2 from a former President of the Royal College of General Practitioners and member of the pathology modernization steering group. It is insu¤cient to overhaul the organization of services without examining how they are used. Conversely, any attempt to control the wider use of clinical services must have its basis in good use of diagnostic testing, on which many clinical activities are based. 3 This paper will consider evidence supporting di¡erences in attitude towards the use of pathology, evidence for mechanisms that have been shown to change requesting behaviour, the impact of health service organizational changes, supporting models to improve appropriateness, and speci¢c models that may be used both to benchmark pathology requesting activity and to create interventions to improve appropriate use of pathology tests. It will not cover the speci¢c areas of evidence-based testing or the diagnostic accuracy of tests, which have been considered in depth elsewhere. 3^7 Although the evidence base is an obvious prerequisite to implementation of good practice, there is in addition a pressing need for a concerted attempt to implement successful strategies that have already been identi¢ed.
The review is directed speci¢cally towards primary care, as this is a sector in which some 90% of testing activity involves a relatively small repertoire of tests 8 and where recent organizational changes o¡er an opportunity to work with primary care colleagues to support good use of tests. It will, however, refer brie£y Personal View to analogous situations in hospitals. Primary care encompasses perhaps not the most expensive of pathology tests, but represents a high and increasing volume of laboratory activity (over 50% in my district). Besides the potential bene¢ts of improved practice, reducing the number, particularly unnecessary repetitions, of tests, greatly decreases costs not only of general practitioner (GP), nurse and phlebotomist time, but also of laboratory non-reagent materials (forms, bottles, collection materials, etc.).
Inappropriate testing and differences in clinical requesting behaviour
If we are to improve the appropriate use of tests we must answer a number of questions:
. 
How do we de ne an inappropriate test?
The appropriateness of tests depends on the clinical context of the patient, the severity of the disorder, administrative necessities and many other factors. Inevitably, interpretation of appropriateness is somewhat subjective. The term`inappropriate' itself is somewhat pejorative as the requestor may well be acting appropriately in terms of the information available to him/her at the time and his/her knowledge of the individual specialty. The term`best practice' more explicitly includes optimiz ing use^both high and low^of tests. Inappropriate tests could be de¢ned as those that could reasonably be avoided at no signi¢cant detriment to a patient's care'. This de¢nition also involves subjectivity in how we de¢ne`signi¢cant detriment'. For example, many laboratories use a`front line' TSH (thyroid-stimulating hormone) assay as the single main test for thyroid function, whereas the USA National Academy of Clinical Biochemistry 9 and the American Thyroid Association 10 recommend that both TSH and free thyroxine be used together to detect and monitor thyroid disease. The 1996 UK consensus statement does not o¡er a clear view on this point, 11 but a recent review in the Continuing Professional Development Bulletin 12 advocates the protocol followed by many laboratories of further testing only in the event of an abnormal initial TSH value. What should we do? It may be argued that use of TSH rather than TSH and thyroxine measurement may be cost-driven, but is this necessarily wrong? Funding will never be in¢nite. The debate must surely be one of cost versus quality, or cost-e¡ectiveness, rather than cost or quality in isolation.
The de¢nition of what is appropriate, or what is best practice in clinical use, therefore requires a consensus view within the profession in the context of each country's national health care system.
Few colleagues would argue that there is an identi-¢able subset of the tests we perform that are truly inappropriate. Many inappropriate tests are administrative in origin: for example, tests duplicated between outpatient clinics and primary care clinics because of inadequate linkage between them. Avoiding such duplication would not be detrimental to patient care. Similarly, many monitoring tests for patients with diabetes, on diuretic therapy or on thyroid replacement are repeated more or less often than necessary because of lack of consensual advice for clinicians or the inability to get that advice accepted. Far down the list come those tests performed despite contrary advice under the guise of`clinical freedom': my experience indicates that most GPs are very receptive to test-appropriateness information.
What is the prevalence of inappropriate testing?
This must be considered in context. The USA spends approximately ¢ve times more on pathology services as a proportion of health care expenditure 13 than the UK, and has a fundamentally di¡erent health care system. Thus, as pointed out in correspondence in Bandolier, 14 it is overly simplistic to rely on ¢gures produced from other health care systems. They do, however, merit being reviewed in the speci¢c context of the British health care system.
Health Trends ran a series of articles in 1984 examining the appropriate use of diagnostic services in general. 15 In his introduction, Rinsler estimated that as much as 30% of work passing through many diagnostic departments might not be necessary and that savings of 10% were realistic. A summary of van Walraven and Naylor's systematic review of (mostly North American) laboratory clinical audits, 16 with both implicit and explicit criteria for appropriateness, found numbers of inappropriate tests ranging from 15% to 56% for all laboratory tests excluding histopathology. The clinical context, disciplines involved and de¢nitions of appropriateness in these studies were all di¡erent, however, and Bandolier 17 concluded overall in 1998 that`the real answer is probably unknowable, but whatever it is it is large'. Similar concepts are echoed by continental colleagues. 18 The Department of Health has identi¢ed a lack of correlation between patterns of clinical referral and health needs. 19 Local data in South Durham have shown large di¡erences for standardized testing activity between general practices across a wide range of pathology tests (see Fig. 1 ), 8 and these di¡erences are not accounted for by di¡erences in practice-list demographics, deprivation indices or organizational features of the practices (type of mini-clinics, number of partners) themselves. 20 A similar study of di¡erences between 174 general practices in the North-East and South-West of England, each covering a population of 1.1 million, has revealed even greater di¡erences for a range of microbiology tests. These have shown a 10-fold or greater di¡erence between the top and bottom quartiles of GP activity.
What interventions are available to reduce inappropriate testing?
Bandolier concludes that many test-requesting problems in pathology are multifactorial and that solving them will therefore require a multifactorial approach. 21 There are many guidelines at local, regional and national level for the use of speci¢ed tests, but production of guidelines alone have been shown to be the least productive way of e¡ecting change. 22 Change will only be brought about with more innovative ways of presenting guidelines to busy doctors and nurses.
Many interventions to in£uence test requesting have been attempted (for detailed review see Reference 23) . Several have targeted speci¢c tests, such as the replacement of iron binding by ferritin measurement, tests for investigating thyroid dysfunction and the content of urea and electrolyte pro¢les. 22 The feedback of costing data has produced a substantial decrease in laboratory testing, 24, 25 but decreasing the cost of testing alone must not be the only goal and must be fully coupled with measures to support best practice. Computerized protocols have also been used successfully, 26, 27 but like test-speci¢c interventions lend themselves most easily to targeted clinical situations and less well to the use by GPs of a range of pathology services. Education is a theme common to many of these interventions, although, as it has been delivered in di¡erent forms, from guidelines through lectures to outreach visits, 28 it is not yet clear what the most successful educational approaches are.
A number of these interventions have potential for application on a wide scale, but there have been few concerted attempts to introduce best-practice interventions across disciplines within pathology; pathology until now has relied on the`seeding'of good practice, often assisted by guidelines or articles in national journals but without a speci¢c framework to organiz e and implement large-scale initiatives.
Can we audit these interventions reliably?
Interventions that are speci¢c to certain tests or clinical situations have successfully measured change, 22, 23 but, whereas an overall reduction in test activity can easily be measured, the ideal of reducing inappropriate excess tests in some users and increasing inappropriately low test activities in others is not so easily assessed. The benchmarking of requesting activity o¡ers a way of detecting change: an intervention that is successful will reduce skewness and therefore inequality of test use and reveal a distribution closer to Gaussian. An example is lipidtesting activity. 29 Standards laid down in a National Service Framework (NSF) document were used in conjunction with laboratory-generated data on test activity and results (1) to devise a standardized testing protocol related to a set of diagnostic options, (2) to o¡er interpretative advice based on the NSF and (3) to derive pertinent audit data for local primary care trusts (PCTs). The question remains, however, what the reference (`appropriate') amount of activity should be for a given test. However, as disease prevalence data are readily available for several diseases, we should be able to predict expected activity if a series of standards were adopted, such as the time intervals for performing monitoring tests in lipid disorders, diabetes and hypertension.
Can the interventions be applied successfully on a large scale?
Past NHS organization has not lent itself easily to addressing issues of best practice in pathology. Policies and practices are frequently constrained by budget, and any budgetary or contracting mechanism that contains neutral or perverse incentives is unlikely to produce improvements in the quality of testing. This has partly changed with the creation of primary care groups and PCTs, together with their clinical governance structures. In this district we have discovered a willingnes s to examine overspending in pathology and to optimize use of testing, in order both to reduce cost and to increase quality of requesting. Joint meetings take place with ¢nance, PCT management, Ann Clin Biochem 2003; 40: 585-592
Figure 2. Schematic depiction of changes in unit test reagent cost for thyroid-stimulating hormone (TSH) versus total laboratory activity at Bishop Auckland General Hospital 1991-2002. TSH is an illustrative example of high-volume endocrine tests. Increases in activity for this test have mirrored overall laboratory test activity, although the change in test cost between 2000 and 2001 includes the effects of a 6-fold increase in contract activity through a multi-site procurement.
clinical governance and laboratory representation to examine possible clinical and contracting mechanisms to reconcile overspending from rising activity with initiatives to improve use of tests.
Reports 30 of the former Clinical Benchmarking Company 1 identi¢ed widespread mismatch of budget and expenditure in clinical biochemistry pathology laboratories. In combination with activity increases, this has led to large overspending on many pathology budgets which, if fully funded, would theoretically deprive PCTs of resources for other areas of medical care. Much of the yearly increase in activity experienced by most laboratories has been o¡set by signi¢cant falls in reagent contract prices over the last 10 years (see Fig. 2 ), but, if these falls plateau, as they appear to be doing, laboratories will face far higher annual increases in costs, compounding the current step-up cost, recruitment and retention issues. There is therefore a need for a structural organization in the PCTs to address best practice and a need for laboratories to examine whether this can be used to change attitudes to test requesting. Methods of contracting are, however, still rudimentary and many contracts are insu¤ciently sensitive to increases in volume of workload to encourage initiatives to in£uence test use, as contracts rarely identify pathology separately in a manner that allows the laboratory to claw back costs for increased work or allows general practices to bene¢t from more judicious use. The result is a cycle of overactivity and laboratory overspend that has been clearly identi¢ed. 30 This must not prevent us from trying, and work from New Zealand 31^33 shows that the necessary budgeting changes can be achieved with good results, although the authors do acknowledge that, while large demonstrable savings were made, it was more di¤cult to demonstrate that quality improved or did not deteriorate.
The benchmarking of testing activity
Laboratory instrument management systems allow large amounts of information to be extracted from the pathology database and are a valuable potential source of information for users. We have examined standardized testing activities across pathology both within hospitals and in primary care as a model to assess di¡erences in requesting behaviour between individual general practices and between trusts. 8 This model can be used to highlight di¡erences and encourage GPs to examine their requesting behaviour and potentially seek advice or take action to change practices. This model also allows interventions to be audited, for example on the use of lipid testing based on an NSF standard 34 as described above. 29 Enlisting the support of users in examining their practice needs to make the process contribute to continuing professional development, rather than being seen as an audit tool with which to beat requesters. Excellent examples of interactive learning for clinical biochemists 35^38 could inspire the extension of the laboratory role to o¡ering similar facilities to users.
Laboratory testing repertoire
Changing the list of tests which make up a given pro¢le can quickly e¡ect change, for example pro¢les of routine electrolyte and liver function tests, those for diagnosing and monitoring thyroid dysfunction, diagnosing the acute coronary syndrome, and urine analysis and microscopy. These changes, whether made on the initiative of an individual laboratory or as a result of changing national trends, produce large changes in test numbers. 22 This type of intervention is possible only when there is widespread consensus on bene¢t, such as in the evolution of thyroid testing.
Changes in the laboratory request form
Several studies have demonstrated the power of the laboratory request form to e¡ect change, usually in combination with other behavioural changes. 22, 23, 39, 40 The move away from test pro¢le requests towards more diagnosis-based requesting undoubtedly enables the laboratory to optimize analyses.
Changing the request forms allows the laboratory to design investigation protocols that are tailored to a diagnosis rather than to a request. Wholesale removal of pro¢les would carry a potential risk of under-testing and might severely strain relationships with clinical colleagues, but changes targeted at improving appropriateness are possible. 22 This laboratory has used two, in lipid measurements as part of the assessment of coronary risk 23 and for thyroid testing (unpublished), and strategies for paraprotein investigation and examination of protocol-based acute out-of-hours tests are entering a pilot phase. The clinical situations of primary and secondary prevention in lipid lowering, and di¡erent clinical questions relating to thyroid status (diagnosis versus monitoring, treatment of thyrotoxicosis versus thyroid replacement therapy) allow di¡erent tests to be selected depending, ¢rstly, on the clinical diagnosis and, secondly, on thè front-line' test result. The same protocols also allow automated interpretative comments to be designed according to the di¡erent situations and results and potentially therefore improve the quality of information returned to GPs for the results that do not require individual biochemist comment.
Similarly, the introduction of emergency admission pro¢les may potentially improve the range of tests performed out of hours. Only one of Solomon's cohort 23 examined emergency laboratory tests: deleting certain coagulation studies from clinical protocols reduced requesting activity. 41 Obvious, perhaps, although whether establishing a set of acute test pro¢les according to the putative admission clinical diagnosis will bene¢t overall good test use remains to be established.
Reinforcing educational factors
Distributing guidelines on correct use of tests alone appears to have a limited impact, 22 probably because colleagues receive so much paperwork they have limited time to digest the content of all of the advice circulated. Pairing reinforced educational guidance with enabling factors such as a change in the request form proved the most successful intervention in Solomon's cohort of 49 studies 42^48 in pathology and radiology. The educational reinforcement took various forms: utilization audits; display of prominent signs; weekly chart reviews; lectures; and computer prompts at time of ordering.
Brief guidance on speci¢c tests, such as a prompt that`LH measurement is not of value in the laboratory diagnosis of the menopause', has produced sustained falls in test use and is a relatively easy manner of providing reinforced education (unpublished data). However, this is limited in the extent to which it may be used if report information is not to become overburdened. Of our own users, some value the additional advice but others wish the reports to be as short as possible.
Gating test activity
Setting criteria whereby tests will not be performed if a request reaches the laboratory appears in theory an attractive way of limiting overtly inappropriate requests, if these can be identi¢ed. Too frequent repetition of monitoring tests, duplication of investigations during a hospital admission and the requesting of out-of-hours tests that do not in£uence immediate patient management are the most obvious examples. However, this approach is confrontational and many argue that the laboratory should check with a user before deleting a test rather than taking a decision unilaterally, since duplication of a test or repeating a test within a short time is not necessarily inappropriate. Contacting requesters is time-consuming, and it is true that, once blood has been taken and the request has reached the laboratory, it is easier to perform the test than to discuss its suitability with users, except in selected cases.
Interventions at the point of requesting
An ideal solution for individual users would be to provide information about best practice in real timeî .e. when the user requests a test. This can potentially bring to a requester's attention the fact that a test has been performed recently, together with its result and guidance over the need for it. This could remove duplication between hospital and primary care and avoid instances where monitoring tests such as measurement of glycated haemoglobin, cholesterol or assessment of thyroid function are repeated frequently. Provided suitable peer-reviewed guidance is available, this is an attractive approach. Systems such as the requesting software from Anglia Systems Ice 1 will allow prompting at the point of request through the use of simple logic rules and of web browser technology to allow real-time access to patients' results in the laboratory database. This o¡ers exciting possibilities for reducing duplicate and other avoidable testing and is being explored for this purpose in South Durham.
Benchmarking and the peer review processes
League tables have been used somewhat controversially to grade hospitals and publish surgical mortality ¢gures. On the understanding that high or low activity does not necessarily mean incorrect activity, benchmarking as described above has been viewed positively by our users.We are currently examining mechanisms for general practices to become involved in a regular process of review in order to examine their use of tests as an integral part of the PCT practice development plan. As the monitoring of pathology use is one of the criteria for achieving Quality Practice awards, there is an incentive for practices to participate in such a scheme. Incentives are needed when users know that only 4% of UK health service expenditure is attributable to pathology, so that few users will be willing to spend more than 4% of their time to consider pathology use. Methods of self-review must be simple, interesting and quick to achieve.
Cross-discipline approach and extension outside pathology
Appropriateness of testing extends beyond biochemistry, and van Walraven's work in 1998 16, 22 covered tests in haematology and microbiology as well, while excluding screening tests and histopathology. There is no reason why the principles outlined above could not be applied to other disciplines, and we have been exploring this possibility by applying the same benchmarking process to radiology and outpatient activity (lipid clinics). A cross-regional microbiology project is currently being established on similar grounds between several hospitals in the North-East and South-West regions, with contributions from across the historical boundaries of the individual disciplines.
Conclusion
Changes in health service structure and funding make it possible for more active interaction between laboratories and primary care trusts in addressing best practice in the use of pathology tests. This requires ongoing dialogue between the laboratory and pathology users and must be seen in a context of mutual help and not one of criticism or prescriptive testing practice. These initiatives will succeed only with the active support both of laboratories and of users and will require the composition of best-practice advice across the range of pathology tests, supported by the professional bodies. Although excellent work has been done, there is a need to bring the matter of appropriateness of testing up the pathology agenda, not just with the production of guidelines but with the design of suitable systems to help improve appropriateness.
On the subject of how to bring about change, Lundberg in 1998 wrote both pessimistically and optimistically. 49, 50 To paraphrase his advice: know the literature; set up an appropriate group; agree terms of reference; implement change; educate; accept positive (and negative) criticism; respond to valid complaints; enjoy a better service. Similar words have come from others. 51 A cross-disciplinary group has recently been formed with representation from the Royal Colleges of General Practitioners and of Pathologists, the Associations of Clinical Pathologists, of Clinical Biochemists and of Medical Microbiologist s, the British Society for Haematology and PRODIGY 52 to examine best practice in primary care. Active support will be needed from interested professionals in all laboratory medicine disciplines and GP colleagues in order to establish a resource of available guidance to support best-practice initiatives.
